Effect of Hyperoncotic Albumin on Vascular Hemodynamics and Oxygen Delivery Following Orthotopic Liver Transplant
Status:
Unknown status
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
The primary aim of this study is to assess the effect of hyperoncotic albumin on vascular
hemodynamics and oxygen delivery after orthotopic liver transplant. The secondary aim is to
try to identify the dominant physiological mechanism so that we will be able to better
identify patients that may benefit from the use of albumin (25%) boluses in addition to
standard care in patients following liver transplantation.
Phase:
Phase 4
Details
Lead Sponsor:
McGill University Health Center McGill University Health Centre/Research Institute of the McGill University Health Centre